IDIBELL researchers discover that a molecule of blood is effective against autoimmune kidney disease

(IDIBELL-Bellvitge Biomedical Research Institute) A research team from IDIBELL identifies C3BP (beta-) as a potential treatment for lupidic nephritis in an animal model.